The selection is based on the dose distribution provided by the prognosis model for the specific patient values.In act 22 of FIG. 1, the selected tumor dose and normal tissue dose, selected dose and associated tolerance, selected probabilities of survival and complication, or other information are input to the inverse treatment planning system.